Dr Anu Anuradha and her research team members
Dr Anu Anuradha, Staff Specialist in the Metro South Public Health Unit, is leading a critical new initiative aimed at improving the health of newborns and reducing hospital admissions caused by Respiratory Syncytial Virus (RSV) infections. Over the past five years, Dr. Anuradha has been at the forefront of public health efforts, combining her expertise in clinical medicine and public health to launch a series of research projects that focus on prevention rather than treatment.
Initially drawn to ophthalmology, she found herself increasingly compelled to expand her focus beyond individual patient care and into broader population health issues.
“It dawned on me that after years of clinical and surgical practice, I was missing the bigger picture,” Dr. Anuradha explained.
“Public health offers the chance to make a significant impact at a population level, which is deeply fulfilling.”
After earning a master’s degree in public health and pursuing a PhD in the field, Dr. Anuradha has spent years bridging her clinical expertise with her academic research. This unique combination has allowed her to focus on evidence-based medicine, working to translate research into practical solutions for the community.
Her most recent project is aimed at reducing the impact of RSV, a leading cause of hospitalisation for infants in the first six months of life. This infectious virus can cause severe respiratory illness, and while most babies recover, some are hospitalised, and in rare cases, it can be fatal. Dr. Anuradha’s research focuses on an innovative immunisation product designed to prevent RSV in newborns. Though not technically a vaccine, the product offers a protective antibody treatment that safeguards babies during their most vulnerable months.
“The first six months of life are critical for newborns, and this immunisation could be a game-changer in reducing hospital admissions,”
“The protection starts to wane over time, but it’s most important in those first six months when babies are most susceptible.”
The research is especially significant given the declining trend in vaccine uptake among certain communities. Dr. Anuradha is concerned that misinformation and complacency around vaccination are contributing to lower immunisation rates.
“We are seeing a concerning drop in immunisation rates, and this is especially true for children. The recent pandemic has only highlighted the importance of prevention—vaccines save lives.”
Dr. Anuradha’s research is focused not only on tracking the efficacy of the immunisation product but also on understanding the barriers to vaccine acceptance. The study will include interviews with parents, particularly mothers, to assess their experiences with the new product, their concerns, and what could be done to improve uptake in high-risk communities.
Her efforts are supported by Metro South Health and a collaborative research grant from the University of Queensland’s School of Public Health. This research will be conducted across two major hospitals in the region, Redland and Logan, which serve a diverse population. With support from the Metro South Research Grant Scheme, Dr. Anuradha aims to generate local evidence on immunisation practices and, ultimately, change the way healthcare is delivered in Queensland and beyond.
“Research should not be seen as a luxury,” she said.
“It needs to be integral to every healthcare professional’s role. By continuously analysing our data and outcomes, we can create practices that benefit our patients, save costs, and improve service delivery.”
“We have seen how one infection can rapidly escalate into a global crisis. It’s not just about treating illnesses when they arise; it’s about preventing them from happening in the first place,” she said.
“That’s why public health is so important—it allows us to stop problems before they start.”
Dr. Anuradha's work continues to inspire a new generation of healthcare professionals, encouraging them to think beyond the confines of clinical care and consider the broader, population-level impacts of their work. Her advocacy for research and evidence-based practices is helping to shape the future of public health, ensuring that the health and wellbeing of future generations are safeguarded through proactive and preventive measures.